Gene blocking and skipping agents known as ASOs or AntiSense Oligos can treat multiple diseases, including the devastating childhood condition Duchenne muscular dystrophy.

Although several PMO drugs have been FDA approved, all have significant limitations which are fundamentally rooted in chemistry. Expertise in ASO design and synthesis can help overcome these challenges and improve upon two decades of scientific research thus far.

We're in Houston - a biomedical innovation capital.
3139 W Holcombe Blvd          Houston TX 77025          info@celurca.com